Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Patrick F. Smith | PRESIDENT DRUG DEV SOLUTIONS | 2024-04-02 | 5,264 | $16.76 | $88.22kSell |
Patrick F. Smith | PRESIDENT DRUG DEV SOLUTIONS | 2024-04-02 | 3,024 | $16.75 | $50.65kSell |
Patrick F. Smith | PRESIDENT DRUG DEV SOLUTIONS | 2024-04-02 | 328 | $17.67 | $5.80kSell |
Patrick F. Smith | PRESIDENT DRUG DEV SOLUTIONS | 2024-04-02 | 4,740 | $16.77 | $79.49kSell |
Patrick F. Smith | PRESIDENT DRUG DEV SOLUTIONS | 2024-04-02 | 649 | $17.72 | $11.50kSell |
Patrick F. Smith | PRESIDENT DRUG DEV SOLUTIONS | 2024-04-02 | 422 | $17.77 | $7.50kSell |
William F. Feehery | CHIEF EXECUTIVE OFFICER | 2024-04-01 | 14,115 | $17.88 | $252.38kSell |
William F. Feehery | CHIEF EXECUTIVE OFFICER | 2024-04-01 | 15,543 | $17.88 | $277.91kSell |
William F. Feehery | CHIEF EXECUTIVE OFFICER | 2024-04-01 | 12,971 | $17.88 | $231.92kSell |
John E. Gallagher | CHIEF FINANCIAL OFFICER | 2024-04-01 | 4,327 | $17.88 | $77.37kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Arsenal Capital Investment Vi LP | 22.74% | 36,345,835 | $597.89M | Insider |
Blackrock Inc | 8.73% | 13,956,611 | $229.59M | Institution |
Vanguard Group Inc | 7.85% | 12,544,560 | $206.36M | Institution |
Mubadala Investment Co Pjsc | 6.02% | 9,615,384 | $158.17M | Institution |
Baillie Gifford Co | 5.58% | 8,921,463 | $146.76M | Institution |
William Blair Investment Management LLC | 4.41% | 7,042,316 | $115.85M | Institution |
Arrowmark Colorado Holdings LLC | 2.63% | 4,202,922 | $69.14M | Institution |
Clearbridge Investments LLC | 2.59% | 4,140,349 | $68.11M | Institution |
Jpmorgan Chase Co | 2.51% | 4,008,269 | $65.94M | Institution |
Wasatch Advisors LP | 2.50% | 3,992,247 | $65.67M | Institution |